Vanderbilt University School of Medicine
Nashville, Tennessee 37232
We've found
9 trials
at this facility
Hematology Clinical Trial
Updated: 12/31/1969
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
RLS Clinical Trial
Updated: 12/31/1969
An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hypothalamic Obesity Clinical Trial
Updated: 12/31/1969
Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Sarcoidosis; Antimycobacterial Therapy Clinical Trial
Updated: 3/26/2018
Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis
Status: Enrolling,
Phase
II
Updated: 3/26/2018
Click here to add this to my saved trials
RLS Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/31/1969
Metabolic Effects of Angiotensin-(1-7)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Reproductive Clinical Trial
Updated: 12/31/1969
Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Updated: 12/31/1969
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials